NasdaqGS:TWSTBiotechs
Twist Bioscience (TWST) Q2 Loss Deepens To US$0.71 EPS And Tests Margin Improvement Story
Q2 2026 earnings snapshot
Twist Bioscience (TWST) has just posted Q2 2026 results with revenue of US$110.7 million and a basic EPS loss of US$0.71, alongside trailing twelve month revenue of US$409.5 million and a trailing EPS loss of US$1.34, giving investors a clear read on both the latest quarter and the recent run rate. Over the past six reported quarters, revenue has moved from US$88.7 million in Q1 2025 to US$110.7 million in Q2 2026, while quarterly basic EPS has ranged from a loss of...